Table 1.
Study | Model | N | Preservation Details/Groups | Length of NMP | Therapeutic Agent(s) | Outcome |
---|---|---|---|---|---|---|
Gillooly et al. 2019 [29] | Rat | N/A | HMP ± siRNA, NMP ± SiRNA, |
4 h | Fas-short interfering RNA (siRNA) | Diffuse uptake of siRNA in both NMP and HMP groups, with increased uptake in the latter. |
Beal et al. 2019 [30] | Rat | 6 per group | NMP, NMP + Enkephalin |
4 h | Enkephalin | Reduced hepatocyte oxidative stress and mitochondrial dysfunction via opioid receptor signalling. |
Moore et al. 2017 [27] | Rat | N/A | NMP | 6 h | p53 siRNA-cy3 | Positive fluorescence for cy3 detected in NMP livers. |
HMP: Hypothermic Machine Perfusion; siRNA: small interfering ribonucleic acid; Enkephalin: D-Ala2, D-Leu5 (DADLE); cy3-dye.